Fenix Innovation Group
7 clinical trials · Sponsor
◉ Watch Fenix Innovation Group
| Record | Firm | Date |
|---|---|---|
| NTI164 in Autism Spectrum Disorder (NCT07257939) | Fenix Innovation Group | 2026-07-01 |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome (NCT07257978) | Fenix Innovation Group | 2026-07-01 |
| NTI164 Human PK Study (NCT06713447) | Fenix Innovation Group | 2024-02-01 |
| Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT) (NCT06621043) | Fenix Innovation Group | 2023-09-20 |
| Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder (NCT05626959) | Fenix Innovation Group | 2022-11-30 |
| Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder. (NCT05516407) | Fenix Innovation Group | 2021-04-01 |
Track Fenix Innovation Group automatically
Every clearance here is in the API, with alerts when new ones post.